Interference with fluorimetric assay of catecholamine by labetalol
- PMID: 715770
- DOI: 10.1620/tjem.126.201
Interference with fluorimetric assay of catecholamine by labetalol
Abstract
Influence of labetalol and 5-(1-hydroxy-2-aminoethyl)salicylamide (SA), a part of the chemical structure of labetalol, on the fluorimetric assay of catecholamine (CA) was studied. Both labetalol and SA have a weak but significant fluorescence which is indistinguishable from that of CA with peaks of excitation/emission wavelengths at 410/490. It is thus concluded that an apparent increase in urinary CA observed in patients receiving labetalol is caused by the contamination of labetalol and/or its metabolite, and that the evaluation of urinary CA in hypertensive patients must be done prior to the use of labetalol to avoid any confusion in diagnosis of pheochromocytoma.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
